Thymidylate synthase polymorphisms and hematological cancer risk: A meta-analysis

Leukemia and Lymphoma

Volumn 53, Issue 7, 2012, Pages 1345-1351

  Weng, Yu ^a   Zhang, Jun ^a   Tang, Xue ^b   Xie, Xinyou ^a   Chen, Guangdi ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

hematological cancer; leukemia; lymphoma; meta analysis; polymorphism; Thymidylate synthase

Indexed keywords

THYMIDYLATE SYNTHASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CANCER RISK; CAUCASIAN; DNA POLYMORPHISM; ETHNICITY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; HUMAN; LEUKEMIA; META ANALYSIS; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; LYMPHOMA, NON-HODGKIN; ODDS RATIO; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; THYMIDYLATE SYNTHASE;

EID: 84862746434     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.649477     Document Type: Article

References (53)

1. Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol 2007;18(Suppl. 1):i3-i8. (Pubitemid 46344633)
2. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Descatha A, Jenabian A, Conso F, et al. Occupational exposures and haematological malignancies: overview on human recent data. Cancer Causes Control 2005;16:939-953. (Pubitemid 41191419)
4. Irigaray P, Newby JA, Clapp R, et al. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother 2007;61:640- 658.
5. Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma. Haematologica 2007;92:960- 969.
6. Koppen IJ, Hermans FJ, Kaspers GJ. Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol 2010;148:3-14.
7. Lehman NL. Future potential of thymidylate synthase inhibitors in cancer therapy. Expert Opin Investig Drugs 2002;11:1775-1787. (Pubitemid 35469921)
8. Horie N, Aiba H, Oguro K, et al. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell struct funct 1995;20:191-197.
9. Kawakami K, Omura K, Kanehira E, et al. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 1999;19:3249-3252. (Pubitemid 30042617)
10. Ulrich CM, Bigler J, Velicer CM, et al. Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 2000;9:1381-1385. (Pubitemid 32044809)
11. Chu J, Dolnick BJ. Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA. Biochim Biophys Acta 2002;1587:183-193. (Pubitemid 34655787)
12. Gao CM, Takezaki T, Wu JZ, et al. Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Asian Pac J Cancer Prev 2004;5:133-138.
13. de Jonge R, Tissing WJ, Hooijberg JH, et al. Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 2009;113:2284-2289.
14. Giovannetti E, Ugrasena DG, Supriyadi E, et al. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia. Leuk Res 2008;32:19-24. (Pubitemid 350100830)
15. Bolufer P, Collado M, Barragan E, et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 2007;92:308-314. (Pubitemid 350143539)
16. Petra BG, Janez J, Vita D. Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma 2007;48:786-792.
17. Lightfoot TJ, Skibola CF, Willett EV, et al. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 2005;14:2999-3003. (Pubitemid 43068838)
18. Hishida A, Matsuo K, Hamajima N, et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 2003;88:159- 166.
19. Skibola CF, Smith MT, Hubbard A, et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002;99:3786-3791. (Pubitemid 34534552)
20. Ongaro A, De Mattei M, Della Porta MG, et al. Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival. Haematologica 2009;94:1391-1398.
21. da Silva Silveira V, Canalle R, Scrideli CA, et al. Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 2009;33:898-901.
22. Dulucq S, St-Onge G, Gagne V, et al. DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL. Blood 2008;111:3692-3700.
23. Rocha JC, Cheng C, Liu W, et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005;105:4752-4758. (Pubitemid 40807300)
24. Krajinovic M, Lemieux-Blanchard E, Chiasson S, et al. Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 2004;4:66-72. (Pubitemid 38256607)
25. Costea I, Moghrabi A, Krajinovic M. The influence of cyclin D1 (CCND1) 870A ≲γτ∀ G polymorphism and CCND1-thymidylate synthase (TS) gene-gene interaction on the outcome of childhood acute lymphoblastic leukaemia. Pharmacogenetics 2003;13:577-580. (Pubitemid 37159635)
26. Lauten M, Asgedom G, Welte K, et al. Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia. Haematologica 2003;88:353-354. (Pubitemid 36358728)
27. Krajinovic M, Costea I, Chiasson S. Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia. Lancet 2002;359:1033-1034. (Pubitemid 34286543)
28. Krajinovic M, Costea I, Primeau M, et al. Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis. Pharmacogenomics J 2005;5:374-380.
29. de Jonge R, Hooijberg JH, van Zelst BD, et al. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. Blood 2005;106:717-720. (Pubitemid 40981271)
30. Liani E, Rothem L, Bunni MA, et al. Loss of folylpoly-gammaglutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. Int J Cancer 2003;103:587-599. (Pubitemid 36091461)
31. Drori S, Jansen G, Mauritz R, et al. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake. J Biol Chem 2000;275:30855-30863.
32. Robien K, Bigler J, Yasui Y, et al. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus- host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 2006;12:973-980.
33. Robien K, Schubert MM, Chay T, et al. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation. Bone Marrow Transplant 2006;37:799-800.
34. Relling MV, Yang W, Das S, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004;22:3930-3936. (Pubitemid 41079875)
35. Chen XW, Yue LJ, Li CG, et al. [Polymorphisms of thymidylate synthase gene detected by RT-PCR-denaturing gradient gel electrophoresis in children with acute leukemia]. Zhongguo Dang Dai Er Ke Za Zhi 2009;11:251-254.
36. Yeoh AE, Lu Y, Chan JY, et al. Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res 2010;34:276-283.
37. Kurzwelly D, Knop S, Guenther M, et al. Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population. J Neurooncol 2010;100:187-192.
38. Chan JY, Ugrasena DG, Lum DW, et al. Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol 2011;29:116-123.
39. Kim HN, Kim YK, Lee IK, et al. Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leuk Res 2009;33:82- 87.
40. Berglund M, Enblad G, Turesson I, et al. Folate-metabolizing genes in lymphoma patients from Sweden. Scand J Immunol 2009;70:408-410.
41. Lima CS, Ortega MM, Ozelo MC, et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leuk Res 2008;32:401-405. (Pubitemid 351295908)
42. Kim HN, Lee IK, Kim YK, et al. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 2008;140:287-294.
43. Kim HN, Kim YK, Lee IK, et al. Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma. Am J Hematol 2007;82:798-801.
44. Niclot S, Pruvot Q, Besson C, et al. Implication of the folatemethionine metabolism pathways in susceptibility to follicular lymphomas. Blood 2006;108:278- 285.
45. Skibola CF, Forrest MS, Coppede F, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004;104:2155- 2162.
46. Canalle R, Silveira VS, Scrideli CA, et al. Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 2011;52:1118-1126.
47. Rahimi Z, Ahmadian Z, Akramipour R, et al. Thymidylate synthase and methionine synthase polymorphisms are not associated with susceptibility to childhood acute lymphoblastic leukemia in Kurdish population from Western Iran. Mol Biol Rep 2011 Jun 5. [Epub ahead of print]
48. Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 2011;34:101-109.
49. McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene 2004;23:6349-6364. (Pubitemid 39265504)
50. Sauer J, Mason JB, Choi SW. Too much folate: a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care 2009;12:30-36.
51. Mandola MV, Stoehlmacher J, Zhang W, et al. A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 2004;14:319- 327.
52. Lincz LF, Scorgie FE, Garg MB, et al. Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R allele. Int J Cancer 2007;120: 1930-1934. (Pubitemid 46418369)
53. Rouissi K, Ouerhani S, Oliveira E, et al. Polymorphisms in onecarbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet 2009;195:43-53.